{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T01:07:19Z","timestamp":1774314439237,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,2]]},"DOI":"10.7759\/cureus.98297","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T12:46:06Z","timestamp":1764679566000},"source":"Crossref","is-referenced-by-count":1,"title":["Pyoderma Gangrenosum Secondary to Melanotan"],"prefix":"10.7759","author":[{"given":"Daniel","family":"Dickson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Hlaing Htwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2011.08.002","article-title":"[Melanotan]","volume":"103","author":"Mahiques-Santos L","year":"2012","unstructured":"Mahiques-Santos L. [Melanotan]. Actas Dermosifiliogr. 2012, 103:257-9. 10.1016\/j.ad.2011.08.002","journal-title":"Actas Dermosifiliogr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-227644","article-title":"Melanotan-induced priapism: a hard-earned tan","volume":"12","author":"Dreyer BA","year":"2019","unstructured":"Dreyer BA, Amer T, Fraser M. Melanotan-induced priapism: a hard-earned tan. BMJ Case Rep. 2019, 12:e227644. 10.1136\/bcr-2018-227644","journal-title":"BMJ Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2165\/11595240-000000000-00000","article-title":"Etiology and management of pyoderma gangrenosum: a comprehensive review","volume":"13","author":"Ahronowitz I","year":"2012","unstructured":"Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. 2012, 13:191-211. 10.2165\/11595240-000000000-00000","journal-title":"Am J Clin Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S61202","article-title":"Pyoderma gangrenosum: challenges and solutions","volume":"8","author":"Gameiro A","year":"2015","unstructured":"Gameiro A, Pereira N, Cardoso JC, Gon\u00e7alo M. Pyoderma gangrenosum: challenges and solutions. Clin Cosmet Investig Dermatol. 2015, 8:285-93. 10.2147\/CCID.S61202","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0308-7","article-title":"Drug-induced pyoderma gangrenosum: a review","volume":"19","author":"Wang JY","year":"2018","unstructured":"Wang JY, French LE, Shear NH, Amiri A, Alavi A. Drug-induced pyoderma gangrenosum: a review. Am J Clin Dermatol. 2018, 19:67-77. 10.1007\/s40257-017-0308-7","journal-title":"Am J Clin Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.13170","article-title":"A case of pyoderma gangrenosum induced by insulin","volume":"16","author":"Noronha M","year":"2019","unstructured":"Noronha M, Arora S, Pai K, Sathish Pai B, Jindal A. A case of pyoderma gangrenosum induced by insulin. Int Wound J. 2019, 16:1239-42. 10.1111\/iwj.13170","journal-title":"Int Wound J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15193","article-title":"Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum","volume":"177","author":"Wu BC","year":"2017","unstructured":"Wu BC, Patel ED, Ortega-Loayza AG. Drug-induced pyoderma gangrenosum: a model to understand the pathogenesis of pyoderma gangrenosum. Br J Dermatol. 2017, 177:72-83. 10.1111\/bjd.15193","journal-title":"Br J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000001140","article-title":"Tyrosine kinase inhibitors-associated pyoderma gangrenosum, a systematic review of published case reports","volume":"33","author":"Khoshnam-Rad N","year":"2022","unstructured":"Khoshnam-Rad N, Gheymati A, Jahangard-Rafsanjani Z. Tyrosine kinase inhibitors-associated pyoderma gangrenosum, a systematic review of published case reports. Anticancer Drugs. 2022, 33:e1-8. 10.1097\/CAD.0000000000001140","journal-title":"Anticancer Drugs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/440396-pyoderma-gangrenosum-secondary-to-melanotan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T12:46:06Z","timestamp":1764679566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/440396-pyoderma-gangrenosum-secondary-to-melanotan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.98297","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,2]]}}}